Cara Therapeutics, Inc. (CARA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 11.96 |
| Open | 11.74 |
| Bid | 12.74 x 800 |
| Ask | 12.76 x 800 |
| Day's range | 11.63 - 12.81 |
| 52-week range | 7.40 - 13.97 |
| Volume | |
| Avg. volume | 342,438 |
| Market cap | 682.668M |
| Beta (5Y monthly) | 0.95 |
| PE ratio (TTM) | 72.15 |
| EPS (TTM) | 0.18 |
| Earnings date | 27 Feb 2023 - 03 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 25.00 |
- Simply Wall St.
Cara Therapeutics Third Quarter 2022 Earnings: Beats Expectations
Cara Therapeutics ( NASDAQ:CARA ) Third Quarter 2022 Results Key Financial Results Revenue: US$10.8m (down 47% from 3Q...
- Zacks
Cara Therapeutics (CARA) Reports Q3 Loss, Tops Revenue Estimates
Cara (CARA) delivered earnings and revenue surprises of -2.38% and 28.91%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Why Cara Therapeutics (CARA) Might Surprise This Earnings Season
Cara Therapeutics (CARA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
© 2022 Yahoo. All rights reserved.
